<DOC>
	<DOCNO>NCT00319826</DOCNO>
	<brief_summary>The purpose study investigate people develop life-threatening infection cause bacteria Staphylococcus aureus , people . It possible infectious ability bacteria determine whether infection develop severity . The investigator look old blood nasal specimen collect 1000 adult S. aureus infection hospitalize Duke University Medical Center . Previously collect health information regard patient specific bacterial trait sample study . Eventually information may use help treat prevent S. aureus infection .</brief_summary>
	<brief_title>Virulence Determinants S Aureus Bacteremia</brief_title>
	<detailed_description>The purpose study thoroughly investigate impact bacterial genetic characteristic outcome patient S. aureus bacteremia ( SAB ) . The investigator address salient aspect bacterial virulence use strong collaborative relationship authority bacterial genetics genomics . The overall hypothesis investigation distinct bacterial virulence determinant influence severity S. aureus infection . The specific hypothesis virulence determinant associated clinical outcome S. aureus infection segregate clonal group , identify Multilocus Sequence Typing ( MLST ) , localize genome comparative genetic hybridization ( CGH ) . The investigator establish follow aim pursue hypothesis . Specific Aim 1 : Define allelic diversity S. aureus bloodstream isolates use MSLT . Allelic profile among 1000 isolates compare use program BURST ( Based Upon Related Sequence Type ) , relatedness lineage overall collection define . Specific Aim 2 : Define genomic diversity S. aureus bloodstream isolates use CGH . Using MLST result , subset 200 isolates select undergo study . These ~200 isolates form unique collection hereafter refer SAGA ( S. aureus genomic analysis ) collection . The genomic diversity SAGA subset define use CGH . Specific Aim 3 : Correlate MLST CGH result , MLST clinical outcome , CGH , clinical outcome , make SAGA isolates available scientific community . In Specific Aim , discriminate ability MLST CGH compare among SAGA subset isolates undergo assay . The association bacterial clonality clinical outcome consider among 1000 S. aureus isolates collect adult Duke University Medical Center S. aureus infection undergo MLST . The association clinical outcome presence absence virulence factor pathogenicity islands S. aureus genome also consider among 200 SAGA subset isolates undergo CGH . The product study include increase understanding genetic diversity S. aureus role genetic diversity determine severity infection cause S. aureus . The full value current proposal also include potential future benefit research community whole association pathogen genotype clinical outcome , possible identify use large clinically well-characterized collection isolates , define . To amplify potential downstream dividend , final goal Specific Aim 3 make SAGA subset isolates , correspond MLST type , CGH profile available scientific community repository maintain Network Antimicrobial Resistance S. aureus ( NARSA ) . The long-term objective project : ( 1 ) identify bacterial gene contribute severity infection isolate large cohort patient SAB ; ( 2 ) ultimately use gene identify novel intervention control S. aureus pathogenesis investigate gene govern virulence emerge pathogen . Culture-confirmed SAB nasal carriage isolate and/or bloodstream bacterial isolate previously collect 1000 inpatient adult Duke University Medical Center use study .</detailed_description>
	<mesh_term>Bacteremia</mesh_term>
	<criteria>1 . Adults ( &gt; = 18 year ) cultureconfirmed Staphylococcus aureus bacteremia ( SAB ) . Patients SAB transfer Duke University Medical Center eligible speculation antibiotic susceptibility confirm Duke Clinical Microbiology Laboratory . 2 . Absolute neutrophil count &gt; 1000 cells/cubic millimeter time initial positive blood culture obtain . 3 . Patient patient 's representative provide sign informed consent allow study participation . 1 . Prior enrollment patient investigation ( ensure statistical independence observation ) . 2 . Staphylococcus aureus bacteremia ( SAB ) confirm culture speciation Duke Clinical Microbiology Laboratory . 3 . Outpatient status . 4 . Isolation pathogen S. aureus bloodstream . 5 . Inability patient patient 's representative provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Staphylococcus aureus , S. aureus , bacteremia , sepsis</keyword>
</DOC>